News | January 17, 2024
Agilent announces new ProteoAnalyzer system
Automated parallel capillary electrophoresis system simplifies protein analysis
Automated parallel capillary electrophoresis system simplifies protein analysis
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
One thousand times more soluble than L-cystine at neutral pH
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
The milestone of operating continuously a very complex system for over two years has demonstrated the effectiveness of integrated laboratory automation solutions
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Sanjeev is currently the Country President for AstraZeneca Malaysia
Collaboration to implement AbTis’ AbClick platform into Lonza’s bioconjugation toolbox
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
Subscribe To Our Newsletter & Stay Updated
